| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(12)61611-0 |
| P698 | PubMed publication ID | 23117178 |
| P2093 | author name string | Independent UK Panel on Breast Cancer Screening | |
| P2860 | cites work | Screening for breast cancer with mammography | Q24234793 |
| Screening for breast cancer: an update for the U.S. Preventive Services Task Force | Q24615837 | ||
| Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England | Q24629668 | ||
| Recommendations on screening for breast cancer in average-risk women aged 40-74 years | Q24633913 | ||
| The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer | Q26852347 | ||
| Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence | Q28244990 | ||
| Interpreting overdiagnosis estimates in population-based mammography screening | Q34195837 | ||
| Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study | Q34471184 | ||
| Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial | Q34478845 | ||
| Long-term effects of mammography screening: updated overview of the Swedish randomised trials | Q34579899 | ||
| The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research | Q34731534 | ||
| Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends | Q34991592 | ||
| Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review | Q37022468 | ||
| Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review | Q38042897 | ||
| Evidence on screening for breast cancer from a randomized trial | Q40779584 | ||
| Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers | Q43248694 | ||
| Psychosocial and sexual impact of diagnosis and treatment of breast cancer | Q43817142 | ||
| Overdiagnosis in breast cancer: design and methods of estimation in observational studies | Q44596742 | ||
| The 2009 breast cancer screening recommendations of the US Preventive Services Task Force | Q44953397 | ||
| Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. | Q50665087 | ||
| The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. | Q50701745 | ||
| Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades | Q61830113 | ||
| P433 | issue | 9855 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| breast cancer screening | Q17011492 | ||
| P304 | page(s) | 1778-1786 | |
| P577 | publication date | 2012-10-30 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The benefits and harms of breast cancer screening: an independent review. | |
| P478 | volume | 380 |
| Q56770825 | Q56770825 |
| Q37356789 | 'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention |
| Q28601090 | 14C BOMB-PULSE DATING AND STABLE ISOTOPE ANALYSIS FOR GROWTH RATE AND DIETARY INFORMATION IN BREAST CANCER? |
| Q33948754 | A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival |
| Q58597281 | A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA |
| Q102323916 | A case-control study to evaluate the impact of the breast screening programme on mortality in England |
| Q30392356 | A definition and ethical evaluation of overdiagnosis: response to commentaries |
| Q96432065 | A dynamic web-based decision aid to improve informed choice in organised breast cancer screening. A pragmatic randomised trial in Italy |
| Q58423594 | A feasibility study of soft embalmed human breast tissue for preclinical trials of HIFU- preliminary results |
| Q52627334 | A national cross-sectional study of adherence to timely mammography use in Malta. |
| Q57274263 | A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening |
| Q57586180 | A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening |
| Q35132988 | A prospective analysis of false positive events in a National Colon Cancer Surveillance Program |
| Q37081913 | A randomised trial of weekend and evening breast screening appointments |
| Q35678095 | A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain. |
| Q92199197 | A systematic review and quality assessment of individualised breast cancer risk prediction models |
| Q50518692 | Abbreviated breast MRI for screening women with dense breast: the EA1141 trial. |
| Q30845709 | Access to early breast cancer diagnosis in the Brazilian Unified National Health System: an analysis of data from the Health Information System |
| Q90854418 | Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia |
| Q44183532 | Addressing the growing international challenge of cancer: a multinational perspective |
| Q35592936 | Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. |
| Q50923589 | Ageing, health, and social care: reframing the discussion. |
| Q34079901 | Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines |
| Q55346639 | Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers. |
| Q58801433 | An Exploratory Application of Eye-Tracking Methods in a Discrete Choice Experiment |
| Q90477760 | An exploration for quantification of overdiagnosis and its effect for breast cancer screening |
| Q35065320 | An ongoing case-control study to evaluate the NHS breast screening programme |
| Q57497824 | Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability |
| Q37178877 | Analysis of motion during the breast clamping phase of mammography |
| Q28083103 | Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast |
| Q90252875 | Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives |
| Q39728241 | Association between Breast Parenchymal Complexity and False-Positive Recall From Digital Mammography Versus Breast Tomosynthesis: Preliminary Investigation in the ACRIN PA 4006 Trial |
| Q39949342 | Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program. |
| Q59796878 | Barriers to and discourses about breast cancer prevention among immigrant women in Spain: a qualitative study |
| Q35555984 | Benefits and harms of mammography screening |
| Q36770273 | Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis |
| Q28072075 | Blood-based DNA methylation as biomarker for breast cancer: a systematic review |
| Q35495804 | Body mass index and participation in organized mammographic screening: a prospective cohort study |
| Q40228495 | Breast Cancer Awareness among Women in Western Amazon: a Population Based Cross-Sectional Study |
| Q28269986 | Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials |
| Q89781949 | Breast Cancer Detection-A Synopsis of Conventional Modalities and the Potential Role of Microwave Imaging |
| Q44446068 | Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change |
| Q27347760 | Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society |
| Q90241672 | Breast cancer |
| Q34271275 | Breast cancer awareness among women in Eastern China: a cross-sectional study. |
| Q34372180 | Breast cancer in European Union: an update of screening programmes as of March 2014 (review) |
| Q51323974 | Breast cancer incidence: Decreasing trend in large tumours in women aged 50-74. |
| Q99626163 | Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark |
| Q34890406 | Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program |
| Q44871804 | Breast cancer mortality trends in Italy by region and screening programme, 1980-2008. |
| Q36027913 | Breast cancer risk and imprinting methylation in blood |
| Q38553884 | Breast cancer screening and diagnosis in the 21st century within the U.K. |
| Q39386534 | Breast cancer screening effect across breast density strata: A case-control study |
| Q41382880 | Breast cancer screening in Austria: Key figures, age limits, screening intervals and evidence |
| Q90186485 | Breast cancer screening in average-risk women: towards personalized screening |
| Q92381881 | Breast cancer screening policy-good science should trump bad politics |
| Q34365123 | Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study. |
| Q38082665 | Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries |
| Q43128186 | Breast cancer screening: time to target women at risk |
| Q46098475 | Breast cancer screening: updated recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations |
| Q36746804 | Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study |
| Q43128213 | Breast screening remains a controversial issue |
| Q44084749 | Breast screening: an obsessive compulsive disorder |
| Q36526116 | CJS debate: Is mammography useful in average-risk screening for breast cancer? |
| Q42229854 | Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting |
| Q93198734 | Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective Study |
| Q90324259 | Can mammogram readers swiftly and effectively learn to interpret first post-contrast acquisition subtracted (FAST) MRI, a type of abbreviated breast MRI?: a single centre data-interpretation study |
| Q38254913 | Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers? |
| Q33854497 | Can mechanical imaging increase the specificity of mammography screening? |
| Q48498909 | Can the synthetic C view images be used in isolation for diagnosing breast malignancy without reviewing the entire digital breast tomosynthesis data set? |
| Q93143827 | Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study |
| Q26786902 | Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials |
| Q26864419 | Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening |
| Q27001043 | Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening |
| Q40595247 | Cause-specific mortality in women with breast cancer in situ |
| Q58693501 | Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women |
| Q35974499 | Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey. |
| Q91305133 | Change in health-related quality of life in older women after diagnosis of a small breast cancer |
| Q39076986 | Characteristics of YouTube™ Videos Related to Mammography |
| Q30238956 | Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model |
| Q38996690 | Clinical implications of genomics for cancer risk genetics |
| Q57105071 | Commentary ACOG Practice Bulletin July 2017: Breast Cancer Risk Assessment and Screening in Average-Risk Women |
| Q30884774 | Commentary: Tempering expectations of screening: what is the most authoritative advice we can give, given the data that we have? |
| Q28069573 | Common methods of measuring 'informed choice' in screening participation: Challenges and future directions |
| Q36269690 | Communicating about overdiagnosis: Learning from community focus groups on osteoporosis |
| Q47304201 | Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. |
| Q51738443 | Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. |
| Q64052205 | Comparison between opportunistic and organised breast cancer mammography screening in the Swiss canton of Fribourg |
| Q28364712 | Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk |
| Q46212925 | Comparison of recommendations for screening mammography using CISNET models |
| Q39480009 | Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families |
| Q36460501 | Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). |
| Q33717272 | Conclusions in systematic reviews of mammography for breast cancer screening and associations with review design and author characteristics. |
| Q38211424 | Controversies in breast cancer screening for women aged 40-49 years |
| Q38273368 | Controversies surrounding screening mammography. |
| Q36831219 | Cost effectiveness of the NHS breast screening programme: life table model |
| Q36276324 | Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review |
| Q36086127 | Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme |
| Q57177092 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model |
| Q37548461 | Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. |
| Q53563765 | Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs. |
| Q34803360 | Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers |
| Q50027418 | Cost-effectiveness of mammography from a publicly funded health care system perspective. |
| Q48334803 | Cross-sectional analyses of participation in cancer screening and use of hormone replacement therapy and medications in meat eaters and vegetarians: the EPIC-Oxford study. |
| Q38828351 | Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening. |
| Q38685947 | Current approach and future perspective for ductal carcinoma in situ of the breast |
| Q90162252 | DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types |
| Q37022322 | Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group. |
| Q90469873 | Decrease in interpretation time for both novice and experienced readers using a concurrent computer-aided detection system for digital breast tomosynthesis |
| Q58732209 | Density and tailored breast cancer screening: practice and prediction - an overview |
| Q61444354 | Deposition of calcium in an in vitro model of human breast tumour calcification reveals functional role for ALP activity, altered expression of osteogenic genes and dysregulation of the TRPM7 ion channel |
| Q35873385 | Design and respondent selection of a population-based study on associations between breast cancer screening, lifestyle and quality of life |
| Q33596111 | Development and evaluation of a decision aid on mammography screening for women 75 years and older |
| Q87990938 | Diagnosing overdiagnosis: conceptual challenges and suggested solutions |
| Q30447039 | Diagnostic performance and inter-observer concordance in lesion detection with the automated breast volume scanner (ABVS). |
| Q35615769 | Diagnostic performance of the automated breast volume scanner: a systematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions |
| Q39562163 | Differences in mortality among women with breast cancer by income - a register-based study in Finland |
| Q39524949 | Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers |
| Q60913037 | Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study |
| Q34370693 | Disparities in cervical and breast cancer mortality in Brazil |
| Q27325711 | Do invitations for cervical screening provide sufficient information to enable informed choice? A cross-sectional study of invitations for publicly funded cervical screening |
| Q55020522 | Does Utilitarian Policy such as Smoking Cessation Lend Support to Wider Aspirin Use? |
| Q35804469 | Does the Neighborhood Area of Residence Influence Non-Attendance in an Urban Mammography Screening Program? A Multilevel Study in a Swedish City |
| Q40127380 | Double versus single reading of mammograms in a breast cancer screening programme: a cost-consequence analysis. |
| Q58721369 | Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation |
| Q91936366 | Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis |
| Q91723932 | Ductal carcinoma in situ: to treat or not to treat, that is the question |
| Q38935395 | Ductal carcinoma in situ: Is core needle biopsy ever enough? |
| Q34483947 | EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). |
| Q36395178 | Early detection of breast cancer in Brazil: data from the National Health Survey, 2013. |
| Q37730583 | Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained? |
| Q50105639 | Editorial: Challenges in Quantifying Overdiagnosis. |
| Q58596506 | Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial |
| Q89407448 | Effect of an organised screening program on socioeconomic inequalities in mammography practice, knowledge and attitudes |
| Q55209578 | Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Cancer Screening Program. |
| Q40135577 | Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women |
| Q37592886 | Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study |
| Q92076018 | Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort |
| Q37160182 | Effectiveness of timed and non-timed second appointments in improving uptake in breast cancer screening |
| Q46932137 | Emerging Trends in Family History of Breast Cancer and Associated Risk |
| Q26861387 | Enhancing cancer care in areas of limited resources: our next steps |
| Q30251732 | Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review |
| Q37382844 | Epidemiology of Breast Cancer - Current Figures and Trends |
| Q57558874 | Epidemiology of Cancer and Principles of Prevention |
| Q39004652 | Epidemiology--a science for the people |
| Q38415175 | Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects |
| Q33758549 | Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes |
| Q47447950 | Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study |
| Q64268308 | Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis |
| Q40158412 | European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France |
| Q90626355 | European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study |
| Q37641214 | Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review |
| Q35896913 | Evaluation of a Mammography Screening Decision Aid for Women Aged 75 and Older: Protocol for a Cluster-randomized Controlled Trial |
| Q30719838 | Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia |
| Q47108636 | Evaluation of the knowledge of women and registered nurses in Japan regarding the benefits and risks of breast cancer screening |
| Q64236276 | Evaluation of the overdiagnosis in breast screening programmes using a Monte Carlo simulation tool: a study of the influence of the parameters defining the programme configuration |
| Q39080255 | Evidence for overuse of medical services around the world |
| Q39296522 | Evolution of Premalignant Disease. |
| Q36709167 | Examining uncertainty in the primary prevention of cardiovascular disease |
| Q30606545 | Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening |
| Q58740067 | Experiences and perceptions about undergoing mammographic screening: a qualitative study involving women from a county in Sweden |
| Q38143347 | Factors influencing participation in breast cancer screening |
| Q35927912 | Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study |
| Q48157024 | Fake facts and alternative truths in medical research |
| Q48187799 | Family doctors should engage with patients about mammography |
| Q36024150 | Forecasting individual breast cancer risk using plasma metabolomics and biocontours |
| Q38904447 | Fragility, uncertainty, and healthcare. |
| Q90737724 | Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program |
| Q34023742 | Green tea compounds in breast cancer prevention and treatment |
| Q36117541 | Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes |
| Q36258712 | How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey. |
| Q92093011 | How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies |
| Q42376772 | How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial |
| Q38401251 | Imaging Surveillance for Survivors of Breast Cancer: Correlation between Cancer Characteristics and Method of Detection |
| Q34452684 | Imaging-based screening: understanding the controversies |
| Q87070703 | Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast |
| Q40365679 | Impact of Breast Reader Assessment Strategy on mammographic radiologists' test reading performance. |
| Q39955038 | Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma |
| Q64119779 | Impact of Overdiagnosis on Long-Term Breast Cancer Survival |
| Q97535478 | Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands |
| Q38963225 | Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial |
| Q34379532 | Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. |
| Q36678269 | Impact of the Introduction of Digital Mammography in an Organized Screening Program on the Recall and Detection Rate |
| Q38937948 | Improvements of an objective model of compressed breasts undergoing mammography: Generation and characterization of breast shapes. |
| Q53477526 | Increasing Cancer Screening Among Old Order Anabaptist Women Through Specialized Women's Health and Integrated Cancer Screening Interventions. |
| Q48190241 | Influence of breast cancer opportunistic screening on aesthetic surgical outcome: A single-center retrospective study in Switzerland |
| Q37070417 | Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening |
| Q35968854 | Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites |
| Q43183243 | Informed decision-making and breast cancer screening. |
| Q48179135 | Infrared spectral histopathology using haematoxylin and eosin (H&E) stained glass slides: a major step forward towards clinical translation. |
| Q57761967 | Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005 |
| Q51033689 | Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. |
| Q40107821 | Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study |
| Q39013634 | Interval cancer rates in the Irish national breast screening programme. |
| Q30241796 | Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries |
| Q34602244 | Interventions to increase the uptake of mammography amongst low income women: a systematic review and meta-analysis |
| Q88098279 | Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models |
| Q36730305 | Is Availability of Mammography Services at Federally Qualified Health Centers Associated with Breast Cancer Mortality-to-Incidence Ratios? An Ecological Analysis |
| Q37152904 | Is clinical breast examination important for breast cancer detection? |
| Q39094483 | Is mammography screening history a predictor of future breast cancer risk? |
| Q64935691 | Is risk-stratified breast cancer screening economically efficient in Germany? |
| Q34247378 | Letter in response to "Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated" |
| Q55251624 | Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells. |
| Q36108606 | Listening to Women: Expectations and Experiences in Breast Imaging |
| Q61445357 | Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study |
| Q45243016 | MRI breast screening in high-risk women: cancer detection and survival analysis |
| Q35786337 | Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction |
| Q34509440 | Mammographic screening debate on study design: a need to move the field forward |
| Q37422270 | Mammographic screening for breast cancer: Are the chickens coming home to roost? |
| Q37389694 | Mammography Screening - as of 2013. |
| Q55010139 | Mammography Screening 2.0 - How Can Risk-Adapted Screening be Implemented in Clinical Practice?: Results of a Focus Group Discussion with Experts in the RISIKOLOTSE.DE Project. |
| Q26778678 | Mammography screening in less developed countries |
| Q35678672 | Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009. |
| Q53349179 | Mammography screening is harmful and should be abandoned. |
| Q40195967 | Mammography screening: please don't be vague, tell me when I should come! |
| Q50320785 | Maximizing gain in high-throughput screening using conformal prediction. |
| Q44222882 | Measuring the mortality impact of breast cancer screening. |
| Q28651176 | Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR) |
| Q42362298 | Mental health interventions for people involved in disasters: what not to do. |
| Q92002111 | Methods Used in Computer-Aided Diagnosis for Breast Cancer Detection Using Mammograms: A Review |
| Q28085699 | Methylation of cell-free circulating DNA in the diagnosis of cancer |
| Q35000210 | Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features |
| Q37593722 | Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study. |
| Q33770344 | Modern mammography screening and breast cancer mortality: population study |
| Q39399933 | Molecular and clinicopathological markers of prognosis in breast cancer. |
| Q35002382 | Molecular breast imaging: an emerging modality for breast cancer screening |
| Q36685380 | Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention |
| Q42557878 | Mortality benefits and overdiagnosis estimates for women attending breast screening |
| Q56395002 | Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study |
| Q39029462 | National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium |
| Q58721785 | Near Field Breast Tumor Detection Using Ultra-Narrow Band Probe with Machine Learning Techniques |
| Q34417148 | Neurological complications of breast cancer: study protocol of a prospective cohort study |
| Q47574102 | New reconstruction algorithm for digital breast tomosynthesis: better image quality for humans and computers |
| Q34568173 | Next steps and barriers to implementing lung cancer screening with low-dose CT. |
| Q26864448 | Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ |
| Q37387989 | No 'cure' within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989-2011. |
| Q47849802 | No myth: Benefits of breast screening |
| Q36416591 | Non-attendance of mammographic screening: the roles of age and municipality in a population-based Swedish sample |
| Q37587664 | Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study. |
| Q58788826 | Non-participation in breast cancer screening among previous cancer patients |
| Q89684306 | Non-participation in mammographic screening - experiences of women from a region in Sweden |
| Q33698278 | Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer |
| Q48250080 | Nudging and the complicated real life of "informed consent". |
| Q30456637 | Occult breast tumor reservoir: biological properties and clinical significance |
| Q53082925 | Offering informed choice about breast screening. |
| Q88933206 | Online information about risks and benefits of screening mammography in 10 European countries: An observational Web sites analysis |
| Q34000716 | Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study |
| Q98164457 | Osteogenic cocktail induces calcifications in human breast cancer cell line via placental alkaline phosphatase expression |
| Q54161798 | Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk. |
| Q34264806 | Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. |
| Q37589081 | Overdiagnosing overdiagnosis |
| Q41542291 | Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands. |
| Q36998186 | Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time |
| Q57169399 | Overdiagnosis in primary care: framing the problem and finding solutions |
| Q60044420 | Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up |
| Q37720423 | Overdiagnosis of breast cancer in population screening: does it make breast screening worthless? |
| Q35078776 | Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study |
| Q41948626 | Overdiagnosis: An Important Issue That Demands Rigour and Precision Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine". |
| Q35438645 | Overdiagnosis: epidemiologic concepts and estimation |
| Q37214228 | Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis |
| Q45063675 | Pan-Canadian study of mammography screening and mortality from breast cancer |
| Q102075418 | Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project |
| Q46350726 | Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study |
| Q42643890 | Patterns, knowledge, and barriers of mammography use among women in Saudi Arabia |
| Q35169592 | People's willingness to accept overdetection in cancer screening: population survey |
| Q47361332 | Performance of 4 years of population-based mammography screening for breast cancer combined with ultrasound in Tyrol / Austria |
| Q36337410 | Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö Breast Tomosynthesis Screening Trial, a population-based study. |
| Q37353842 | Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older |
| Q48349394 | Personality and breast cancer screening in women of the GAZEL cohort study. |
| Q86721150 | Perspective: The risks of overdiagnosis |
| Q38383069 | Phyllodes tumour among participants in screening mammography |
| Q42369801 | Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance |
| Q35714470 | Point: Mammography screening-sticking to the science |
| Q64273148 | Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies |
| Q38185110 | Position paper: breast cancer screening, diagnosis, and treatment in Denmark |
| Q35763721 | Preconceptions influence women's perceptions of information on breast cancer screening: a qualitative study |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q38125030 | Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery |
| Q48159653 | Preferences for Communicating about Breast Cancer Screening Among Racially/Ethnically Diverse Older Women. |
| Q35876054 | Pregnant Women's Perceptions of Harms and Benefits of Mental Health Screening |
| Q38171320 | Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis. |
| Q34655579 | Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q37185723 | Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre |
| Q34354430 | Prostate-specific antigen screening in prostate cancer: perspectives on the evidence |
| Q40904735 | Psychological impact of breast cancer screening in Japan. |
| Q57266318 | Psychological impact of providing women with personalised 10-year breast cancer risk estimates |
| Q90201795 | Psychometric properties of the Breast Cancer Awareness Measurement among Chinese women: a cross-sectional study |
| Q35629000 | Public Opinions about Overdiagnosis: A National Community Survey |
| Q93172480 | Public awareness of and responses to media coverage of invitation errors in the Breast Screening Programme in England: a cross-sectional population survey |
| Q86499074 | Public health implications from COGS and potential for risk stratification and screening |
| Q51411883 | Quality assurance target for community-based breast cancer screening in China: a model simulation. |
| Q47631573 | Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology. |
| Q35755246 | Quantifying disparities in cancer incidence and mortality of Australian residents of New South Wales (NSW) by place of birth: an ecological study. |
| Q37235493 | Quantifying the natural history of breast cancer |
| Q37327859 | Racial/ethnic disparities in annual mammogram compliance among households in Little Haiti, Miami-Dade County, Florida: An observational study. |
| Q55445540 | Radiologists can detect the 'gist' of breast cancer before any overt signs of cancer appear. |
| Q37235581 | Re-attendance after false-positive screening mammography: a population-based study in the Netherlands. |
| Q34639851 | Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group |
| Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
| Q60045746 | Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer |
| Q41065061 | Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort |
| Q51245901 | Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study. |
| Q38796787 | Research needs in breast cancer. |
| Q51759726 | Resistance to Discontinuing Breast Cancer Screening in Older Women: A Qualitative Study. |
| Q57414750 | Response to Hersch et al |
| Q36169940 | Response to: "Beyond the mammography debate: a moderate perspective". |
| Q36989170 | Response to: "[Miller's] Response to: 'Beyond the mammography debate: a moderate perspective'". |
| Q51313302 | Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. |
| Q47100005 | Risk Factors and Preventions of Breast Cancer |
| Q26774591 | Risk factors and biomarkers of life-threatening cancers |
| Q92804731 | Risk of breast cancer by prior screening results among women participating in BreastScreen Norway |
| Q33454007 | Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App. |
| Q33909792 | Satisfaction, discomfort, obligations, and concerns in population-based breast cancer screening: cross-sectional study in a Danish population |
| Q60923372 | Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer |
| Q34041688 | Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. |
| Q88200057 | Screening and surveillance-principles and practice |
| Q55396634 | Screening for breast cancer in 2018-what should we be doing today? |
| Q24202273 | Screening for breast cancer with mammography |
| Q40557575 | Screening for cervical and breast cancer |
| Q34653876 | Screening for disease, psychological testing, and psychotherapy Looking behind the mirror |
| Q33699944 | Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies |
| Q26829839 | Screening mammography in older women: a review |
| Q30851278 | Screening mammography--early detection or over-diagnosis? Contribution from Australian data |
| Q35353726 | Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts |
| Q24186492 | Screening with urinary dipsticks for reducing morbidity and mortality |
| Q39132236 | Screening-detected non-symptomatic breast cancer: a case history |
| Q40308627 | Screening: Don't look now. |
| Q35134216 | Screening: The information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening |
| Q28088369 | Secondary solid cancer screening following hematopoietic cell transplantation |
| Q41950880 | Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial |
| Q55461099 | Silent diffuse low-grade glioma: toward screening and preventive treatment? |
| Q47094586 | Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions. |
| Q42682794 | Societal costs and effects of implementing population-based mammography screening in Greenland |
| Q40142965 | Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study. |
| Q36865049 | Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? |
| Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
| Q30679405 | Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer |
| Q59137331 | Strong association between cervical and breast cancer screening behaviour among Danish women; A register-based cohort study |
| Q36819006 | Survey of public definitions of the term 'overdiagnosis' in the UK. |
| Q33891746 | Survival of Node-negative Breast Cancer Patients Treated at the University Medical Centre Maribor in the Period 2000-2009. |
| Q38126067 | Systematic review about breast cancer incidence in relation to hormone replacement therapy use. |
| Q37190825 | Targeted therapy for breast cancer prevention |
| Q37674652 | Testing whether barriers to a hypothetical screening test affect unrelated perceived benefits and vice versa: A randomised, experimental study |
| Q35198330 | Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population. |
| Q35813007 | The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database |
| Q39320375 | The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening |
| Q37708613 | The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model |
| Q53057894 | The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer. |
| Q52983883 | The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition. |
| Q43128206 | The Marmot report: accepting the poisoned chalice |
| Q36070933 | The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment |
| Q38665126 | The UK breast screening program - what you need to know |
| Q38937235 | The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges |
| Q33875850 | The basic facts of korean breast cancer in 2011: results of a nationwide survey and breast cancer registry database |
| Q43590652 | The benefits and harms of breast cancer screening |
| Q44210450 | The benefits and harms of breast cancer screening |
| Q95544002 | The benefits and harms of breast cancer screening |
| Q95544004 | The benefits and harms of breast cancer screening |
| Q95544006 | The benefits and harms of breast cancer screening |
| Q95544008 | The benefits and harms of breast cancer screening |
| Q95544011 | The benefits and harms of breast cancer screening |
| Q95544013 | The benefits and harms of breast cancer screening |
| Q56994674 | The benefits and harms of breast cancer screening |
| Q86774582 | The benefits and harms of breast cancer screening |
| Q27347267 | The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model |
| Q30578410 | The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial |
| Q37660353 | The effect of local therapy on breast cancer mortality: is there an age-interaction? |
| Q90799109 | The effect of organized breast cancer screening on mammography use: Evidence from France |
| Q37254463 | The effects of a UK review of Breast Cancer Screening on Uptake: an observational before/after study |
| Q28386746 | The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry |
| Q35275317 | The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older women |
| Q33917618 | The impact of overdiagnosis on the selection of efficient lung cancer screening strategies |
| Q57188533 | The importance of enabling informed decision making for women considering breast cancer screening |
| Q39252030 | The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study |
| Q58577343 | The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening |
| Q38955479 | The menopause specialist and breast cancer survivorship |
| Q37690088 | The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study |
| Q35946329 | The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions |
| Q35660389 | The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study |
| Q28386208 | The relative effect of mammographic screening on breast cancer mortality by socioeconomic status |
| Q54482443 | The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal. |
| Q35813074 | The role of communication in breast cancer screening: a qualitative study with Australian experts |
| Q35030034 | The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice. |
| Q92736802 | The use of 'Think-Out-Loud' methodology in the development of teaching materials for abbreviated breast Magnetic Resonance Imaging scan (FAST MRI) interpretation, and a comparison of the learning experience of two reader cohorts |
| Q39147763 | Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives. |
| Q52838790 | Three-dimensional reconstruction of ductal carcinoma in situ with virtual slides. |
| Q39083717 | Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50. |
| Q92804538 | Towards clinical grating-interferometry mammography |
| Q37172721 | Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer |
| Q35102711 | Translational cancer research: balancing prevention and treatment to combat cancer globally |
| Q30244636 | Treatment of low-risk ductal carcinoma in situ: is nothing better than something? |
| Q36547885 | Trends in UK regional cancer mortality 1991-2007. |
| Q46588380 | Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution |
| Q38094973 | Trends in breast cancer incidence and mortality in the United States: implications for prevention |
| Q38421948 | Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway |
| Q38919259 | Trends in cancer in the elderly population in Denmark, 1980-2012. |
| Q34982039 | Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. |
| Q40077849 | Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography |
| Q93035710 | Trends of mortality due to breast cancer in Poland, 2000-2016 |
| Q99712021 | Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ |
| Q52573652 | Uncertain times: A survey of Canadian women's perspectives toward mammography screening. |
| Q39021524 | Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer |
| Q37357513 | Updated results of the Gothenburg Trial of Mammographic Screening |
| Q57188538 | Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial |
| Q51065588 | Use of text-message reminders to improve participation in a population-based breast cancer screening program. |
| Q33830508 | Using evidence to combat overdiagnosis and overtreatment: evaluating treatments, tests, and disease definitions in the time of too much |
| Q38232148 | Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers. |
| Q97093695 | Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort |
| Q35640397 | Values in breast cancer screening: an empirical study with Australian experts |
| Q99608099 | Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study |
| Q50094493 | Visibility of mammographically occult breast cancer on diffusion-weighted MRI versus ultrasound. |
| Q35640556 | What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians |
| Q45867222 | What's a girl to do? |
| Q40723108 | Why reconsider the recommendation of breast cancer screening? |
| Q35105050 | Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content |
| Q39463159 | Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers |
| Q55315231 | Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals. |
| Q34116973 | Women's participation in breast cancer screening in France--an ethical approach |
| Q92216468 | Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study |
| Q36809821 | Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. |
| Q30532790 | Women's views on overdiagnosis in breast cancer screening: a qualitative study |
| Q38683422 | Words do matter: a systematic review on how different terminology for the same condition influences management preferences |
| Q87249665 | [Limits of mammography screening: current controversies and perspectives] |
| Q57697332 | “I Was Trying to Do the Maths”: Exploring the Impact of Risk Communication in Discrete Choice Experiments |
Search more.